GPT and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD were more likely to be heavier and had significantly enhanced levels of SBP, DBP, FIN, ALT, AST, γ-GGT, TC, TG, FBG, LDL-C, SUA, and HOMA-IR and decreased levels of HDL compared to those without NAFLD.